Evidence check: TCF7L2 in the context of longevity

TCF7L2 is one of the most robustly replicated GWAS loci for type 2 diabetes risk. Since diabetes is a major contributor to morbidity and mortality, variants in TCF7L2 could indirectly affect longevity. However, the effect size is modest and heavily modulated by lifestyle (diet, physical activity). Direct evidence linking TCF7L2 to human lifespan is lacking; most studies focus on diabetes as an intermediate trait. Additionally, associations are ancestry-specific. A direct-to-consumer DNA test reporting a TCF7L2 variant does not provide a direct longevity prediction, but rather a risk factor that can be mitigated. The evidence is strong for diabetes risk (GWAS) but weak for longevity per se. Consumers should be cautious about overinterpreting such findings.